ProCE Banner Activity

Slides: Precision Medicine Approaches in the Management of Cholangiocarcinoma

Slideset Download
Review this slideset on the current treatment of cholangiocarcinoma with expert perspectives from Christine Chio, PharmD, BCOP; Lipika Goyal, MD; and Caroline Kuhlman, NP.

Released: May 13, 2022

Expiration: May 12, 2023

Share

Faculty

Christine Chio

Christine Chio, PharmD, BCOP

Clinical Ambulatory GI Oncology Pharmacist
Department of Pharmacy
Massachusetts General Hospital
Boston, Massachusetts

Lipika Goyal

Lipika Goyal, MD, MPhil

Associate Professor of Medicine
Director of Gastrointestinal Medical Oncology
Stanford Cancer Center
Palo Alto, California

Caroline Kuhlman

Caroline Kuhlman, MSN, APRN-BC

Nurse Practitioner, Tucker Gosnell Center for Gastrointestinal Cancers
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Incyte Corporation

Faculty Disclosure

Primary Author

Christine Chio, PharmD, BCOP

Clinical Ambulatory GI Oncology Pharmacist
Department of Pharmacy
Massachusetts General Hospital
Boston, Massachusetts

Christine Chio, PharmD, BCOP, has no relevant conflicts of interest to report.

Lipika Goyal, MD, MPhil

Associate Professor of Medicine
Director of Gastrointestinal Medical Oncology
Stanford Cancer Center
Palo Alto, California

Lipika Goyal, MD, has disclosed that she has received consulting fees from Alentis Therapeutics, Black Diamond, Genentech, H3 Biomedicine, Incyte, Mefial, QED, Servier, Sirtex, and Taiho Oncology.

Caroline Kuhlman, MSN, APRN-BC

Nurse Practitioner, Tucker Gosnell Center for Gastrointestinal Cancers
Massachusetts General Hospital
Boston, Massachusetts

Caroline Kuhlman, NP, has no relevant conflicts of interest to report.